The Dangers of Delaying Care for Seniors

Understanding RSV in Older Adults
Respiratory syncytial virus (RSV) can be more than just a common cold for older adults. It can quickly lead to serious, sometimes life-threatening complications.
Common Symptoms of RSV
RSV symptoms can mimic a cold or the flu, including coughing, sneezing, fever, and a runny nose. For older adults, these symptoms can turn into difficulty breathing and wheezing (a high pitched whistling sound when exhaling.)
Signs of Trouble
To help prevent pneumonia or other serious complications, be on the lookout for signs that your RSV infection is getting worse. Get medical attention right away if you have shortness of breath, wheezing, a worsening cough, or there is a bluish tint to your skin (a sign of reduced oxygen in the blood.)
Serious Complications
RSV can lead to severe health problems such as pneumonia or respiratory failure, when your breathing becomes more difficult, and less oxygen enters the bloodstream. It may also cause congestive heart failure. If you have asthma, COPD, or heart failure, RSV can make your condition worse.
How RSV Is Diagnosed
Doctors often diagnose people based on a physical exam and the time of year the symptoms occur. For moderate or serious RSV in older adults, they may also use a rapid diagnostic test. This involves taking a nasal sample and testing it to determine what type of virus you have.
Treatment Options
Home remedies include plenty of rest, lots of fluids, and keeping a humidifier handy. You can also use pain relievers like ibuprofen. If symptoms worsen, you may need to go to the hospital for oxygen therapy and fluids.
Preventing RSV
You can help prevent RSV by washing your hands, disinfecting surfaces, and using hand sanitizer. The best way to protect yourself and others is to get vaccinated. The CDC recommends the RSV vaccine for all adults ages 75 and older, and for people ages 60-74 who have certain health conditions.
Photo Credits:
Monkey Business Images/Shutterstock
SOURCES:
CDC: “RSV in Older Adults and Adults with Chronic Medical Conditions,” “Respiratory Syncytial Virus Infection (RSV),” “RSV in Infants and Young Children.”
Human Vaccines & Immunotherapeutics: “Estimating the burden of adult hospitalized RSV infection using local and state data methodology.”
Journal of the American College of Cardiology: “Respiratory Syncytial Virus and Associations with Cardiovascular Disease in Adults.”
National Foundation for Infectious Diseases: “Respiratory Syncytial Virus in Older Adults: A Hidden Annual Epidemic,” “Respiratory Syncytial Virus Infection (RSV).”
PLOS One: “Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure – United States, 2015-2017.”
Journal of Chronic Obstructive Pulmonary Disease: “Risk Factors for Respiratory Syncytial Virus Illness Among Patients with Chronic Obstructive Pulmonary Disease, COPD.”
Mayo Clinic: “Respiratory syncytial virus (RSV).”
Pfizer: “Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate.”